Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is it possible?

Not if signed last quarter. Possible if signed since.

PTSC's revenue recognition policy is as follows:

"Revenue from technology license agreements is recognized at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), and the customer is provided with the licensed technology, if applicable."

So if GE or Motorola signed before the end of 11/2011, the revenue from that contract SHOULD BE contained in the 10q PDS numbers. If done after November, then we should see the revenue in the next 10q.

Corrections welcome.

Share
New Message
Please login to post a reply